Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America

Open access

Abstract

BACKGROUND: Cardiovascular disease and non-AIDS malignancies have become major causes of death among HIV-infected individuals. The relative impact of lifestyle and HIV-related factors are debated. METHODS: We estimated associations of smoking with mortality more than 1 year after antiretroviral therapy (ART) initiation among HIV-infected individuals enrolled in European and North American cohorts. IDUs were excluded. Causes of death were assigned using standardized procedures. We used abridged life tables to estimate life expectancies. Life-years lost to HIV were estimated by comparison with the French background population. RESULTS: Among 17,995 HIV-infected individuals followed for 79,760 person-years, the proportion of smokers was 60%. The mortality rate ratio (MRR) comparing smokers with nonsmokers was 1.94 [95% confidence interval (95% CI) 1.56-2.41]. The MRRs comparing current and previous smokers with never smokers were 1.70 (95% CI 1.23-2.34) and 0.92 (95% CI 0.64-1.34), respectively. Smokers had substantially higher mortality from cardiovascular disease, non-AIDS malignancies than nonsmokers [MRR 6.28 (95% CI 2.19-18.0) and 3.31 (95% CI 1.80-5.45), respectively]. [corrected]. Among 35-year-old HIV-infected men, the loss of life-years associated with smoking and HIV was 7.9 (95% CI 7.1-8.7) and 5.9 (95% CI 4.9-6.9), respectively. The life expectancy of virally suppressed, never-smokers was 43.5 years (95% CI 41.7-45.3), compared with 44.4 years among 35-year-old men in the background population. Excess MRRs/1000 person-years associated with smoking increased from 0.6 (95% CI -1.3 to 2.6) at age 35 to 43.6 (95% CI 37.9-49.3) at age at least 65 years. CONCLUSION: Well treated HIV-infected individuals may lose more life years through smoking than through HIV. Excess mortality associated with smoking increases markedly with age. Therefore, increases in smoking-related mortality can be expected as the treated HIV-infected population ages. Interventions for smoking cessation should be prioritized.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qad.0000000000000540

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Excess mortality and loss of life years.
Fig. 1 Excess mortality and loss of life years.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 268

Metadata

Authors
Helleberg, M., May, M. T., Ingle, S. M., Dabis, F., Reiss, P., Fätkenheuer, G., Costagliola, D., d’Arminio, A., Cavassini, M., Smith, C., Justice, A. C., Gill, J., Sterne, J. A. C., & Obel, N.
Affiliations
  • University of Copenhagen (DK)
  • University of Bristol (GB)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • University of Cologne (DE)
  • Inserm (FR)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • University College London (GB)
  • Yale University (US)
Corresponding author
Helleberg, Marie
Venue
AIDS
Published
2015-01-14
Volume
29
Issue
2
Pages
221-229
ISSN
0269-9370 (ISSN-L)
OpenAlex
W1993551104
Cited by
268
References
34
Citations by year
2026: 8 · 2025: 18 · 2024: 21 · 2023: 12 · 2022: 19 · 2021: 19 · 2020: 33 · 2019: 26 · 2018: 30 · 2017: 38 · 2016: 30 · 2015: 13
FWCI
28.70
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • AIDS (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • IRIS (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • Bristol Research (University of Bristol) (submittedVersion, cc-by-nc-nd)
  • SERVAL (Université de Lausanne) (submittedVersion, other-oa)
Funders
  • National Science Foundation
  • U.S. Department of Veterans Affairs
  • Bristol-Myers Squibb
  • Pfizer
  • Styrelsen för Internationellt Utvecklingssamarbete
  • Gilead Sciences
  • Office of Research and Development
  • ViiV Healthcare
  • Michael Smith Health Research BC
  • National Institute for Health and Care Research (NF-SI-0611-10168)
  • Institut National de la Santé et de la Recherche Médicale
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (134277)
  • Department for International Development
  • Stichting HIV Monitoring
  • Canadian Institutes of Health Research (U24-AA020794)
  • Medical Research Council (MR/J002380/1)
  • National Institute on Alcohol Abuse and Alcoholism (U01AA020790, U10AA013566, U24AA020794)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
smoking, HIV infection, antiretroviral therapy, life expectancy, mortality, cardiovascular disease, years of life lost, smoking cessation, HIV mortality, lifestyle risk factors, viral suppression, abridged life tables, mortality rate ratio, age-specific mortality risk, tobacco control
MeSH terms
Adult, Europe, Female, Humans, Life Expectancy, Male, Middle Aged, North America, Smoking, Cohort Studies, HIV Infections, CD4 Lymphocyte Count, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. https://app.cochat.ai/papers/10.1097/qad.0000000000000540
The paper
Helleberg, M., May, M. T., Ingle, S. M., Dabis, F., Reiss, P., Fätkenheuer, G., Costagliola, D., d’Arminio, A., Cavassini, M., Smith, C., Justice, A. C., Gill, J., Sterne, J. A. C., & Obel, N. (2015). Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. https://doi.org/10.1097/qad.0000000000000540

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.